<table width="638px" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<thead>
<tr>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">Table 7. Erosive Esophagitis Patient Healing Rates</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top"></td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">Healed / Evaluable</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top"></td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">Placebo* <br/>n=229</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">Ranitidine Tablets, USP<br/>150 mg q.i.d.*<br/>n=215</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">Week 4</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">43/198 (22%)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">96/206 (47%) †</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">Week 8</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">63/176 (36%)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">142/200 (71%) †</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">Week 12</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">92/159 (58%)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">162/192 (84%) †</td>
</tr>
</tbody>
</table>